Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
The novel combination is attuned specifically to the needs of specialists in nuclear medicine. The flat panel provides localization and attenuation correction at a lower cost than CT and with less technological complexity, so the system doesn't require special training for technologists, according to the company.
A side benefit is a two-thirds reduction in patient x-ray dose compared with MSCT. The XCT design is compact enough to allow siting in the same 12 x 15-foot room as the SPECT camera alone.
The system is scheduled to begin shipping next year at a price point somewhere between the company's $700,000 six-slice Precedence SPECT/CT and the $350,000 BrightView SPECT gamma camera. Beta testing is expected to begin in Q1 2009.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.